Soficitinib is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related autoimmune disorders. The Current indications under development are ...

In this video from the American Academy of Ophthalmology meeting, Lejla Vajzovic, MD, FASRS, highlights a presentation on macular telangiectasia type 2.

DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, and Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), ...

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that i ...

Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s ...

Whether your family is affected by Alzheimer's or you simply want to learn more about the disease, this conference in Boca ...

First presentation of U.S. IDE clinical data shows statistically significant improvements in pain and function at 24 months compared with fusion surgery ...

Detailed price information for Precision Biosciences Inc (DTIL-Q) from The Globe and Mail including charting and trades.

BioLife Solutions ( ($BLFS) ) has issued an update. On November 17, 2025, BioLife Solutions released an investor presentation highlighting its ...

Only cases of alleged murder, rape or manslaughter will be decided by a jury under new proposals to cut court backlogs.

Linus Health, an AI-driven brain health company pioneering early detection of cognitive impairment and personalized intervention, will present new evidence validating its AI-enabled tools for early ...